check_circleStudy Completed

Prostate Cancer

Bayer Identifier:

14166

ClinicalTrials.gov Identifier:

NCT00908674

EudraCT Number:

Not Available

EU CT Number:

Not Available
Androcur Effects on Quality of Life

Trial purpose

Androcur is an antiandrogenic drug, which blocks the action of male sex hormones. Androcur is used for treatment of advanced prostate cancer. This study investigates the effect of Androcur on quality of life of prostate cancer patients who are taking the drug for 12 months

Key Participants Requirements

Sex

Male

Age

18 Years
  • - Histologically confirmed adenocarcinoma of the prostate
    - Inoperable prostate tumor or progradiated after surgery/ irradiation therapy
    - Locally advanced tumor or distant metastases is present
  • - Patient not fulfil the recruitment criteria
    - Liver disease; Dubin-Johnson syndrome; Rotor syndrome; previous or existing liver tumours (in carcinoma of the prostate only if these are not due to metastases); wasting diseases (with the exception of carcinoma of the prostate); depression; previous or existing thromboembolic processes; diabetes with vascular changes; sickle-cell anaemia.
    - As regards patients with prostatic carcinoma who have a history of thromboembolic processes and/or an existing sickle-cell anaemia, or diabetes with vascular changes, the risk:benefit ratio must be considered carefully in each individual case before the use of Androcur

Trial summary

Enrollment Goal
245
Trial Dates
June 2008 - January 2010
Phase
N/A
Could I Receive a placebo
No
Products
Androcur (Cyproterone Acetate, BAY94-8367)
Accepts Healthy Volunteer
No

Where to participate

StatusInstitutionLocation
Completed
Many Locations, Hungary

Primary Outcome

  • Quality of life change measured by SF-35 questionnaire
    date_rangeTime Frame:
    Baseline, after 3, 6 and 12 month
    enhanced_encryption
    Safety Issue:
    No

Trial design

Measure of Androcur Effects on Quality of Life at Prostate Cancer Patients
Trial Type
Observational
Intervention Type
Drug
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.